Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Encapsulation of Cardamom Essential Oil in Chitosan Nano-composites: In-vitro Efficacy on Antibiotic-Resistant Bacterial Pathogens and Cytotoxicity Studies.

Jamil B, Abbasi R, Abbasi S, Imran M, Khan SU, Ihsan A, Javed S, Bokhari H, Imran M.

Front Microbiol. 2016 Oct 4;7:1580. eCollection 2016.

2.

Multidrug-Resistant Staphylococcus aureus, India, 2013-2015.

Kumar M.

Emerg Infect Dis. 2016 Sep;22(9):1666-7. doi: 10.3201/eid2209.160044. No abstract available.

3.

Identification and treatment of the Staphylococcus aureus reservoir in vivo.

Surewaard BG, Deniset JF, Zemp FJ, Amrein M, Otto M, Conly J, Omri A, Yates RM, Kubes P.

J Exp Med. 2016 Jun 27;213(7):1141-51. doi: 10.1084/jem.20160334. Epub 2016 Jun 20. Erratum in: J Exp Med. 2016 Dec 12;213(13):3087.

4.

Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.

Hu HC, Kao KC, Chiu LC, Chang CH, Hung CY, Li LF, Liu TP, Lin LC, Chen NH, Huang CC, Yang CT, Lu JJ.

BMC Infect Dis. 2015 Oct 23;15:444. doi: 10.1186/s12879-015-1215-2.

5.

Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus.

Keshipeddy S, Reeve SM, Anderson AC, Wright DL.

J Am Chem Soc. 2015 Jul 22;137(28):8983-90. doi: 10.1021/jacs.5b01442. Epub 2015 Jul 8.

6.

Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens.

Busetti A, Thompson TP, Tegazzini D, Megaw J, Maggs CA, Gilmore BF.

Mar Drugs. 2015 Jun 5;13(6):3581-605. doi: 10.3390/md13063581.

7.

Parallel Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Infection in North and South America.

Planet PJ, Diaz L, Kolokotronis SO, Narechania A, Reyes J, Xing G, Rincon S, Smith H, Panesso D, Ryan C, Smith DP, Guzman M, Zurita J, Sebra R, Deikus G, Nolan RL, Tenover FC, Weinstock GM, Robinson DA, Arias CA.

J Infect Dis. 2015 Dec 15;212(12):1874-82. doi: 10.1093/infdis/jiv320. Epub 2015 Jun 5.

8.

Whole-genome sequencing for outbreak investigations of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice?

Azarian T, Cook RL, Johnson JA, Guzman N, McCarter YS, Gomez N, Rathore MH, Morris JG, Salemi M.

Infect Control Hosp Epidemiol. 2015 Jul;36(7):777-85. doi: 10.1017/ice.2015.73. Epub 2015 May 8.

9.

Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection.

Wang F, Gao W, Thamphiwatana S, Luk BT, Angsantikul P, Zhang Q, Hu CM, Fang RH, Copp JA, Pornpattananangkul D, Lu W, Zhang L.

Adv Mater. 2015 Jun 10;27(22):3437-43. doi: 10.1002/adma.201501071. Epub 2015 Apr 30. No abstract available.

10.

The membrane protein PrsS mimics σS in protecting Staphylococcus aureus against cell wall-targeting antibiotics and DNA-damaging agents.

Krute CN, Bell-Temin H, Miller HK, Rivera FE, Weiss A, Stevens SM, Shaw LN.

Microbiology. 2015 May;161(Pt 5):1136-48. doi: 10.1099/mic.0.000065. Epub 2015 Mar 4.

11.

Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.

Schmelcher M, Shen Y, Nelson DC, Eugster MR, Eichenseher F, Hanke DC, Loessner MJ, Dong S, Pritchard DG, Lee JC, Becker SC, Foster-Frey J, Donovan DM.

J Antimicrob Chemother. 2015 May;70(5):1453-65. doi: 10.1093/jac/dku552. Epub 2015 Jan 27.

12.

Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study.

Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SM, McCormick JK, Mele T.

CMAJ Open. 2014 Oct 1;2(4):E352-9. doi: 10.9778/cmajo.20140018. eCollection 2014 Oct.

13.

Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa.

Busetti A, Shaw G, Megaw J, Gorman SP, Maggs CA, Gilmore BF.

Mar Drugs. 2014 Dec 24;13(1):1-28. doi: 10.3390/md13010001.

14.

IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction.

Swierstra J, Debets S, de Vogel C, Lemmens-den Toom N, Verkaik N, Ramdani-Bouguessa N, Jonkman MF, van Dijl JM, Fahal A, van Belkum A, van Wamel W.

Infect Immun. 2015 Feb;83(2):492-501. doi: 10.1128/IAI.02286-14. Epub 2014 Nov 17.

15.

Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase.

Capodagli GC, Lee SA, Boehm KJ, Brady KM, Pegan SD.

Biochemistry. 2014 Dec 9;53(48):7604-14. doi: 10.1021/bi501141t. Epub 2014 Nov 21.

16.

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii.

Tiwari V, Tiwari M.

Front Microbiol. 2014 Sep 26;5:512. doi: 10.3389/fmicb.2014.00512. eCollection 2014. Review.

17.

Chemical Composition, Modulatory Bacterial Resistance and Antimicrobial Activity of Essential Oil the Hyptis martiusii Benth by Direct and Gaseous Contact.

de Oliveira AD, Galvao Rodrigue FF, Douglas Melo Coutinho H, da Costa JG, de Menezes IR.

Jundishapur J Nat Pharm Prod. 2014 Jun 29;9(3):e13521. eCollection 2014 Aug.

18.

Another success story for horizontal infection control strategies--which one?*.

Popovich KJ.

Crit Care Med. 2014 Oct;42(10):2292-3. doi: 10.1097/CCM.0000000000000566. No abstract available.

19.

Prevalence and characterization of methicillin-resistant Staphylococcus aureus isolates from healthy university student athletes.

Champion AE, Goodwin TA, Brolinson PG, Werre SR, Prater MR, Inzana TJ.

Ann Clin Microbiol Antimicrob. 2014 Aug 2;13:33. doi: 10.1186/s12941-014-0033-5.

20.

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Patel DA, Shorr AF, Chastre J, Niederman M, Simor A, Stephens JM, Charbonneau C, Gao X, Nathwani D.

Crit Care. 2014 Jul 22;18(4):R157. doi: 10.1186/cc13996.

Supplemental Content

Support Center